• Something wrong with this record ?

Formulation Development, Physicochemical Characterization and In Vitro-In Vivo Drug Release of Vaginal Films

K. Ghosal, BT. Hazra, BB. Bhowmik, S. Thomas,

. 2016 ; 14 (4) : 295-306.

Language English Country Netherlands

Document type Journal Article

PURPOSE: The purpose of this study was formulation and optimization of vaginal film formulation containing abacavir (ABC), a potent nucleoside reverse transcriptase inhibitor. METHODS: Vaginal films were prepared by solvent evaporation method using hydroxypropyl methylcellulose (HPMC) blended with polyvinyl pyrrolidone (PVP). Various physicochemical parameters of the prepared films such as drug content, thickness, tensile strength, percentage elongation at break, drug polymer interaction, swelling capacity, folding endurance, bio-adhesion, pH, and moisture content were evaluated with morphological studies. In vitro release study and in vivo release study were also performed. RESULTS: Films exhibited favorable physicochemical properties. The in vitro study showed that HPMC-PVP combination can control the release of abacavir through vaginal films with higher amount of PVP in the formulation resulting in an enhanced drug release rate. During the in vivo study in rabbits, systemic absorption of the drug was noted and the films remained intact for long in vagina without causing any sort of irritations. CONCLUSION: Thus, in a nutshell, the findings of our experimental work indicate that such films can be considered as a novel drug carrier system for the treatment of AIDS and other sexually transmitted diseases (STDs), and are suitable for local as well as systemic effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031884
003      
CZ-PrNML
005      
20171101102640.0
007      
ta
008      
171025s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1570162x14666151113123040 $2 doi
035    __
$a (PubMed)26564015
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ghosal, Kajal $u Flat No: 26, 10 Vychodilova, Zaboversky 2551, Brno 61600, Czech Republic. kaju_3_ju@rediffmail.com.
245    10
$a Formulation Development, Physicochemical Characterization and In Vitro-In Vivo Drug Release of Vaginal Films / $c K. Ghosal, BT. Hazra, BB. Bhowmik, S. Thomas,
520    9_
$a PURPOSE: The purpose of this study was formulation and optimization of vaginal film formulation containing abacavir (ABC), a potent nucleoside reverse transcriptase inhibitor. METHODS: Vaginal films were prepared by solvent evaporation method using hydroxypropyl methylcellulose (HPMC) blended with polyvinyl pyrrolidone (PVP). Various physicochemical parameters of the prepared films such as drug content, thickness, tensile strength, percentage elongation at break, drug polymer interaction, swelling capacity, folding endurance, bio-adhesion, pH, and moisture content were evaluated with morphological studies. In vitro release study and in vivo release study were also performed. RESULTS: Films exhibited favorable physicochemical properties. The in vitro study showed that HPMC-PVP combination can control the release of abacavir through vaginal films with higher amount of PVP in the formulation resulting in an enhanced drug release rate. During the in vivo study in rabbits, systemic absorption of the drug was noted and the films remained intact for long in vagina without causing any sort of irritations. CONCLUSION: Thus, in a nutshell, the findings of our experimental work indicate that such films can be considered as a novel drug carrier system for the treatment of AIDS and other sexually transmitted diseases (STDs), and are suitable for local as well as systemic effects.
650    _2
$a aplikace intravaginální $7 D000282
650    _2
$a zvířata $7 D000818
650    _2
$a látky proti HIV $x aplikace a dávkování $x farmakokinetika $7 D019380
650    _2
$a chemické jevy $7 D055598
650    _2
$a dideoxynukleosidy $x aplikace a dávkování $x farmakokinetika $7 D015224
650    12
$a lékové formy $7 D004304
650    _2
$a nosiče léků $x aplikace a dávkování $x chemie $7 D004337
650    12
$a příprava léků $7 D004339
650    12
$a uvolňování léčiv $7 D065546
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a králíci $7 D011817
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hazra, Bipad Taran
700    1_
$a Bhowmik, Benoy Brata
700    1_
$a Thomas, Sabu
773    0_
$w MED00007898 $t Current HIV research $x 1873-4251 $g Roč. 14, č. 4 (2016), s. 295-306
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26564015 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171101102732 $b ABA008
999    __
$a ok $b bmc $g 1255477 $s 992911
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 14 $c 4 $d 295-306 $i 1873-4251 $m Current HIV research $n Curr HIV Res $x MED00007898
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...